Last 12 months
Inside the activity.
12 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 6 | 0 |
| Mar 2026 | 0 | 14 |
| Apr 2026 | 0 | 0 |
| May 2026 | 6 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 7, 2026 20:02 UTC |
Cox Bryan F.Chief of Research
|
SaleCommon Stock | 296 | $4.39 | $1,299.44 |
DisclosureSEC source: 0001628280-26-065326 · wk-form4_1791403369.xml · nonDerivative · entry 1 Cox Bryan F. · CIK 0001981787 · Chief of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,805 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:02 UTC |
Marshak RichardChief Commercial Officer
|
SaleCommon Stock | 325 | $4.39 | $1,426.75 |
DisclosureSEC source: 0001628280-26-065325 · wk-form4_1791403362.xml · nonDerivative · entry 1 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,994 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:02 UTC |
Stevens JenniferChief Regulatory Officer
|
SaleCommon Stock | 316 | $4.39 | $1,387.24 |
DisclosureSEC source: 0001628280-26-065324 · wk-form4_1791403354.xml · nonDerivative · entry 1 Stevens Jennifer · CIK 0001982621 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,794 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. Read SEC document |
| October 05, 2026 Filed Oct 7, 2026 20:02 UTC |
Szela Mary TDirector · CEO and President
|
Tax withholdingCommon Stock | 2,693 | $4.38 | $11,795.34 |
DisclosureSEC source: 0001628280-26-065323 · wk-form4_1791403347.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074,990 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 20:01 UTC |
Patience DavidChief Financial Officer
|
Tax withholdingCommon Stock | 14,650 | $4.46 | $65,339.00 |
DisclosureSEC source: 0001628280-26-047217 · wk-form4_1783368070.xml · nonDerivative · entry 1 Patience David · CIK 0001970009 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,107 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:02 UTC |
Marshak RichardChief Commercial Officer
|
GrantCommon Stock | 561 | $3.87 | $2,171.07 |
DisclosureSEC source: 0001628280-26-046507 · wk-form4_1782936164.xml · nonDerivative · entry 1 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,319 F1 · shares: Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 20:04 UTC |
Szela Mary TDirector · CEO and President
|
GrantCommon Stock | 3,990 | $3.87 | $15,441.30 |
DisclosureSEC source: 0001628280-26-046519 · wk-form4_1782936285.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,077,683 F1 · shares: Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 20:33 UTC |
Marshall Richard HenryChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001628280-26-046015 · wk-form4_1782765207.xml · derivative · entry 2 Marshall Richard Henry · CIK 0002142265 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,000 Underlying: Common Stock · 120,000 shares Expires 2036-06-29 F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 20:33 UTC |
Marshall Richard HenryChief Medical Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-046015 · wk-form4_1782765207.xml · nonDerivative · entry 1 Marshall Richard Henry · CIK 0002142265 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:42 UTC |
Gordon Gary B.Director
|
PurchaseCommon Stock | 10,000 | $2.46 | $24,600.00 |
DisclosureSEC source: 0001628280-26-035991 · wk-form4_1779136936.xml · nonDerivative · entry 1 Gordon Gary B. · CIK 0001811354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,510 Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:42 UTC |
Wahlstrom MatsDirector
|
PurchaseCommon Stock | 60,000 | $2.53 | $151,800.00 |
DisclosureSEC source: 0001628280-26-035996 · wk-form4_1779136958.xml · nonDerivative · entry 1 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,555 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:42 UTC |
Stansky Michael PDirector
|
PurchaseCommon Stock | 200,000 | $2.50 | $500,000.00 |
DisclosureSEC source: 0001628280-26-035995 · wk-form4_1779136952.xml · nonDerivative · entry 2 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Skyview Investments LLC Disclosed balance after: 399,698 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F3 · ownership.nature: The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. Read SEC document |
| May 15, 2026 Filed May 18, 2026 16:42 UTC |
Stansky Michael PDirector
|
PurchaseCommon Stock | 410,000 | $2.50 | $1,025,000.00 |
DisclosureSEC source: 0001628280-26-035995 · wk-form4_1779136952.xml · nonDerivative · entry 1 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240,722 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:42 UTC |
Szela Mary TDirector · CEO and President
|
PurchaseCommon Stock | 39,682 | $2.59 | $102,776.38 |
DisclosureSEC source: 0001628280-26-035994 · wk-form4_1779136946.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,065,215 F1 · kind: The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 39,682 shares at a weighted average price of $2.59, with the Reporting Person's sales of 4,358 shares of common stock at a price per share of $4.13 on March 11, 2026 and of 15,944 shares of common stock at a price per share of $3.85. The prior sales represented shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person, and did not represent discretionary sales by the Reporting Person. The Reporting Person paid $27,573.70 to the Issuer, representing the full amount of profit realized in connection with the short-swing transaction. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.62 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:42 UTC |
Patience DavidChief Financial Officer
|
PurchaseCommon Stock | 7,100 | $2.43 | $17,253.00 |
DisclosureSEC source: 0001628280-26-035992 · wk-form4_1779136942.xml · nonDerivative · entry 1 Patience David · CIK 0001970009 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,757 Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:08 UTC |
Marshak RichardChief Commercial Officer
|
SaleCommon Stock | 543 | $2.67 | $1,449.81 |
DisclosureSEC source: 0001628280-26-036427 · wk-form4_1779221287.xml · nonDerivative · entry 1 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,101 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
HICKS KERRY RDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 56,403 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035669 · wk-form4_1778877571.xml · derivative · entry 5 HICKS KERRY R · CIK 0001110473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,625 Underlying: Common Stock · 56,403 shares Expires 2036-05-13 F5 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
HICKS KERRY RDirector
|
GrantCommon Stock | 28,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035669 · wk-form4_1778877571.xml · nonDerivative · entry 1 HICKS KERRY R · CIK 0001110473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542,790 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Valle WilliamDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 56,403 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035663 · wk-form4_1778877546.xml · derivative · entry 3 Valle William · CIK 0002018493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,653 Underlying: Common Stock · 56,403 shares Expires 2036-05-13 F3 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Valle WilliamDirector
|
GrantCommon Stock | 24,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035663 · wk-form4_1778877546.xml · nonDerivative · entry 2 Valle William · CIK 0002018493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,241 F2 · shares: Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Valle WilliamDirector
|
GrantCommon Stock | 28,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035663 · wk-form4_1778877546.xml · nonDerivative · entry 1 Valle William · CIK 0002018493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,688 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Gordon Gary B.Director
|
GrantDirector Stock Option (right to buy) · Derivative | 56,403 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035665 · wk-form4_1778877558.xml · derivative · entry 3 Gordon Gary B. · CIK 0001811354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,653 Underlying: Common Stock · 56,403 shares Expires 2036-05-13 F3 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Gordon Gary B.Director
|
GrantCommon Stock | 24,553 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035665 · wk-form4_1778877558.xml · nonDerivative · entry 2 Gordon Gary B. · CIK 0001811354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,510 F2 · shares: Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Gordon Gary B.Director
|
GrantCommon Stock | 28,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035665 · wk-form4_1778877558.xml · nonDerivative · entry 1 Gordon Gary B. · CIK 0001811354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,957 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Wahlstrom MatsDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 75,204 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035667 · wk-form4_1778877563.xml · derivative · entry 5 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,149 Underlying: Common Stock · 75,204 shares Expires 2036-05-13 F5 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Wahlstrom MatsDirector
|
GrantCommon Stock | 34,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035667 · wk-form4_1778877563.xml · nonDerivative · entry 2 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,555 F2 · shares: Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Wahlstrom MatsDirector
|
GrantCommon Stock | 37,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035667 · wk-form4_1778877563.xml · nonDerivative · entry 1 Wahlstrom Mats · CIK 0001459154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,329 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Stansky Michael PDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 47,003 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035662 · wk-form4_1778877538.xml · derivative · entry 4 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,540 Underlying: Common Stock · 47,003 shares Expires 2036-05-13 F4 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Stansky Michael PDirector
|
GrantCommon Stock | 20,089 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035662 · wk-form4_1778877538.xml · nonDerivative · entry 2 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 830,722 F2 · shares: Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
Stansky Michael PDirector
|
GrantCommon Stock | 23,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035662 · wk-form4_1778877538.xml · nonDerivative · entry 1 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 810,633 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
MATLIN DAVID JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 56,403 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001628280-26-035664 · wk-form4_1778877552.xml · derivative · entry 3 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,403 Underlying: Common Stock · 56,403 shares Expires 2036-05-13 F3 · derivative.exercise_date: The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
MATLIN DAVID JDirector
|
GrantCommon Stock | 23,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035664 · wk-form4_1778877552.xml · nonDerivative · entry 2 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,323,210 F2 · shares: Represents grant of restricted stock units (the "Retainer RSU Award") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 14, 2026 Filed May 15, 2026 20:39 UTC |
MATLIN DAVID JDirector
|
GrantCommon Stock | 28,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-035664 · wk-form4_1778877552.xml · nonDerivative · entry 1 MATLIN DAVID J · CIK 0001251956 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300,145 F1 · shares: Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| March 17, 2026 Filed Mar 20, 2026 20:25 UTC |
Szela Mary TDirector · CEO and President
|
SaleCommon Stock | 15,944 | $3.85 | $61,384.40 |
DisclosureSEC source: 0001628280-26-020186 · wk-form4_1774038323.xml · nonDerivative · entry 2 Szela Mary T · CIK 0001410289 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 752,987 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 16:25 UTC |
Devlin JodiChief of Clinical Operations
|
SaleCommon Stock | 273 | $4.12 | $1,124.76 |
DisclosureSEC source: 0001628280-26-020190 · wk-form4_1774038352.xml · nonDerivative · entry 3 Devlin Jodi · CIK 0001992151 · Chief of Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,364 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 16:25 UTC |
Stevens JenniferChief Regulatory Officer
|
SaleCommon Stock | 774 | $4.12 | $3,188.88 |
DisclosureSEC source: 0001628280-26-020187 · wk-form4_1774038332.xml · nonDerivative · entry 3 Stevens Jennifer · CIK 0001982621 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,110 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 20:25 UTC |
Marshak RichardChief Commercial Officer
|
SaleCommon Stock | 419 | $4.12 | $1,726.28 |
DisclosureSEC source: 0001628280-26-020188 · wk-form4_1774038338.xml · nonDerivative · entry 3 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,397 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 20:25 UTC |
Cox Bryan F.Chief of Research
|
SaleCommon Stock | 579 | $4.12 | $2,385.48 |
DisclosureSEC source: 0001628280-26-020189 · wk-form4_1774038346.xml · nonDerivative · entry 3 Cox Bryan F. · CIK 0001981787 · Chief of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,415 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 12, 2026 Filed Mar 20, 2026 16:25 UTC |
Devlin JodiChief of Clinical Operations
|
SaleCommon Stock | 1,772 | $4.09 | $7,247.48 |
DisclosureSEC source: 0001628280-26-020190 · wk-form4_1774038352.xml · nonDerivative · entry 2 Devlin Jodi · CIK 0001992151 · Chief of Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,637 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 12, 2026 Filed Mar 20, 2026 16:25 UTC |
Stevens JenniferChief Regulatory Officer
|
SaleCommon Stock | 1,552 | $4.09 | $6,347.68 |
DisclosureSEC source: 0001628280-26-020187 · wk-form4_1774038332.xml · nonDerivative · entry 2 Stevens Jennifer · CIK 0001982621 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,884 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 12, 2026 Filed Mar 20, 2026 20:25 UTC |
Marshak RichardChief Commercial Officer
|
SaleCommon Stock | 1,589 | $4.09 | $6,499.01 |
DisclosureSEC source: 0001628280-26-020188 · wk-form4_1774038338.xml · nonDerivative · entry 2 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,816 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 12, 2026 Filed Mar 20, 2026 20:25 UTC |
Cox Bryan F.Chief of Research
|
SaleCommon Stock | 1,467 | $4.09 | $6,000.03 |
DisclosureSEC source: 0001628280-26-020189 · wk-form4_1774038346.xml · nonDerivative · entry 2 Cox Bryan F. · CIK 0001981787 · Chief of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,994 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 20, 2026 16:25 UTC |
Devlin JodiChief of Clinical Operations
|
SaleCommon Stock | 1,162 | $4.13 | $4,799.06 |
DisclosureSEC source: 0001628280-26-020190 · wk-form4_1774038352.xml · nonDerivative · entry 1 Devlin Jodi · CIK 0001992151 · Chief of Clinical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,409 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 20, 2026 16:25 UTC |
Stevens JenniferChief Regulatory Officer
|
SaleCommon Stock | 1,204 | $4.13 | $4,972.52 |
DisclosureSEC source: 0001628280-26-020187 · wk-form4_1774038332.xml · nonDerivative · entry 1 Stevens Jennifer · CIK 0001982621 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,436 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 20, 2026 20:25 UTC |
Marshak RichardChief Commercial Officer
|
SaleCommon Stock | 1,449 | $4.13 | $5,984.37 |
DisclosureSEC source: 0001628280-26-020188 · wk-form4_1774038338.xml · nonDerivative · entry 1 Marshak Richard · CIK 0001982638 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,405 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 20, 2026 20:25 UTC |
Szela Mary TDirector · CEO and President
|
SaleCommon Stock | 4,358 | $4.13 | $17,998.54 |
DisclosureSEC source: 0001628280-26-020186 · wk-form4_1774038323.xml · nonDerivative · entry 1 Szela Mary T · CIK 0001410289 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 768,931 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| March 11, 2026 Filed Mar 20, 2026 20:25 UTC |
Cox Bryan F.Chief of Research
|
SaleCommon Stock | 1,138 | $4.13 | $4,699.94 |
DisclosureSEC source: 0001628280-26-020189 · wk-form4_1774038346.xml · nonDerivative · entry 1 Cox Bryan F. · CIK 0001981787 · Chief of Research 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,461 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person. Read SEC document |
| February 23, 2026 Filed Feb 23, 2026 21:08 UTC |
Valle WilliamDirector
|
PurchaseCommon Stock | 30,487 | $4.10 | $124,996.70 |
DisclosureSEC source: 0001628280-26-010604 · wk-form4_1771880892.xml · nonDerivative · entry 1 Valle William · CIK 0002018493 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,487 Read SEC document |
| February 23, 2026 Filed Feb 23, 2026 21:08 UTC |
Gordon Gary B.Director
|
PurchaseCommon Stock | 9,756 | $4.10 | $39,999.60 |
DisclosureSEC source: 0001628280-26-010605 · wk-form4_1771880900.xml · nonDerivative · entry 1 Gordon Gary B. · CIK 0001811354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,756 Read SEC document |
| February 23, 2026 Filed Feb 23, 2026 21:08 UTC |
Stansky Michael PDirector
|
PurchaseCommon Stock | 117,198 | $4.10 | $480,511.80 |
DisclosureSEC source: 0001628280-26-010602 · wk-form4_1771880877.xml · nonDerivative · entry 2 Stansky Michael P · CIK 0001424204 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 199,698 F1 · ownership.nature: These securities were purchased by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.